Mark W. Lingen to Endothelium, Vascular
This is a "connection" page, showing publications Mark W. Lingen has written about Endothelium, Vascular.
Connection Strength
0.648
-
Endothelial cell migration assay. A quantitative assay for prediction of in vivo biology. Methods Mol Med. 2003; 78:337-47.
Score: 0.188
-
Prediction of in vivo synergistic activity of antiangiogenic compounds by gene expression profiling. Cancer Res. 2002 Dec 15; 62(24):7143-8.
Score: 0.187
-
Inhibition of squamous cell carcinoma angiogenesis by direct interaction of retinoic acid with endothelial cells. Lab Invest. 1996 Feb; 74(2):476-83.
Score: 0.116
-
Role of leukocytes and endothelial cells in the development of angiogenesis in inflammation and wound healing. Arch Pathol Lab Med. 2001 Jan; 125(1):67-71.
Score: 0.041
-
Retinoic acid and interferon alpha act synergistically as antiangiogenic and antitumor agents against human head and neck squamous cell carcinoma. Cancer Res. 1998 Dec 01; 58(23):5551-8.
Score: 0.035
-
Retinoic acid induces cells cultured from oral squamous cell carcinomas to become anti-angiogenic. Am J Pathol. 1996 Jul; 149(1):247-58.
Score: 0.030
-
Myofibromas of the oral cavity. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1995 Sep; 80(3):297-302.
Score: 0.028
-
Methylnaltrexone inhibits opiate and VEGF-induced angiogenesis: role of receptor transactivation. Microvasc Res. 2006 Jul-Sep; 72(1-2):3-11.
Score: 0.015
-
Captopril inhibits angiogenesis and slows the growth of experimental tumors in rats. J Clin Invest. 1996 Aug 01; 98(3):671-9.
Score: 0.008